113 related articles for article (PubMed ID: 8057670)
61. Role of the bcl-2 oncogene in Hodgkin's disease.
Inghirami G; Frizzera G
Am J Clin Pathol; 1994 Jun; 101(6):681-3. PubMed ID: 8209851
[No Abstract] [Full Text] [Related]
62. Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma.
Pezzella F; Jones M; Ralfkiaer E; Ersbøll J; Gatter KC; Mason DY
Br J Cancer; 1992 Jan; 65(1):87-9. PubMed ID: 1733447
[TBL] [Abstract][Full Text] [Related]
63. Detection of specific t(14;18) chromosomal translocations in fixed tissues.
Shibata D; Hu E; Weiss LM; Brynes RK; Nathwani BN
Hum Pathol; 1990 Feb; 21(2):199-203. PubMed ID: 2307446
[TBL] [Abstract][Full Text] [Related]
64. Use of archival and fresh cytologic material for the polymerase chain reaction. Detection of the bcl-2 oncogene in lymphoid tissue obtained by fine needle biopsy.
Kube MJ; McDonald DA; Quin JW; Greenberg ML
Anal Quant Cytol Histol; 1994 Jun; 16(3):174-82. PubMed ID: 7916845
[TBL] [Abstract][Full Text] [Related]
65. Quantification of t(14;18) in the lymphocytes of healthy adult humans as a possible biomarker for environmental exposures to carcinogens.
Fuscoe JC; Setzer RW; Collard DD; Moore MM
Carcinogenesis; 1996 May; 17(5):1013-20. PubMed ID: 8640906
[TBL] [Abstract][Full Text] [Related]
66. BCL6 alternative breakpoint region break and homozygous deletion of 17q24 in the nodular lymphocyte predominance type of Hodgkin's lymphoma-derived cell line DEV.
Atayar C; Kok K; Kluiver J; Bosga A; van den Berg E; van der Vlies P; Blokzijl T; Harms G; Davelaar I; Sikkema-Raddatz B; Martin-Subero JI; Siebert R; Poppema S; van den Berg A
Hum Pathol; 2006 Jun; 37(6):675-83. PubMed ID: 16733207
[TBL] [Abstract][Full Text] [Related]
67. Somatic point mutations in the translocated bcl-2 genes of non-Hodgkin's lymphomas and lymphocytic leukemias: implications for mechanisms of tumor progression.
Reed JC; Tanaka S
Leuk Lymphoma; 1993 Jun; 10(3):157-63. PubMed ID: 8220113
[TBL] [Abstract][Full Text] [Related]
68. Topographical dissociation of BCL-2 messenger RNA and protein expression in human lymphoid tissues.
Chleq-Deschamps CM; LeBrun DP; Huie P; Besnier DP; Warnke RA; Sibley RK; Cleary ML
Blood; 1993 Jan; 81(2):293-8. PubMed ID: 8422456
[TBL] [Abstract][Full Text] [Related]
69. [Apoptosis in Hodgkin's disease].
Lorenzen J; Alavaikko M; Hansmann ML
Pathologe; 1995 May; 16(3):208-16. PubMed ID: 7792273
[TBL] [Abstract][Full Text] [Related]
70. The t(14;18) translocation in Hodgkin's disease.
Stetler-Stevenson M
J Natl Cancer Inst; 1992 Dec; 84(23):1770-1. PubMed ID: 1433363
[No Abstract] [Full Text] [Related]
71. Oncogenes in Hodgkin's disease.
Jones DB; Cossman J; Hansmann ML
Ann Oncol; 1992 Sep; 3 Suppl 4():9-12. PubMed ID: 1333273
[TBL] [Abstract][Full Text] [Related]
72. Semi-automated ELISA-based detection system for verifying the authenticity of amplified t(14;18)-containing products.
Segal GH; Scott M; Braylan RC
Diagn Mol Pathol; 1996 Jun; 5(2):114-20. PubMed ID: 8727098
[TBL] [Abstract][Full Text] [Related]
73. Hodgkin's disease: chromosomes and genetics.
Bastard C
Leukemia; 1996 Jun; 10 Suppl 2():s72-3. PubMed ID: 8649057
[No Abstract] [Full Text] [Related]
74. The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation.
Chen-Levy Z; Nourse J; Cleary ML
Mol Cell Biol; 1989 Feb; 9(2):701-10. PubMed ID: 2651903
[TBL] [Abstract][Full Text] [Related]
75. Down regulation of bcl-2 by p53 in nasopharyngeal carcinoma and lack of detection of its specific t(14;18) chromosomal translocation in fixed tissues.
Harn HJ; Ho LI; Liu CA; Liu GC; Lin FG; Lin JJ; Chang JY; Lee WH
Histopathology; 1996 Apr; 28(4):317-23. PubMed ID: 8732340
[TBL] [Abstract][Full Text] [Related]
76. The bcl-2 gene, follicular lymphoma, and Hodgkin's disease.
Cleary M; Rosenberg SA
J Natl Cancer Inst; 1990 May; 82(10):808-9. PubMed ID: 2185366
[No Abstract] [Full Text] [Related]
77. Cytogenetic features of Hodgkin's disease suggest possible origin from a lymphocyte.
Cabanillas F; Pathak S; Trujillo J; Grant G; Cork A; Hagemeister FB; Velasquez WS; McLaughlin P; Redman J; Katz R
Blood; 1988 Jun; 71(6):1615-7. PubMed ID: 3370310
[TBL] [Abstract][Full Text] [Related]
78. t(14;18), a journey to eternity.
Meijerink JP
Leukemia; 1997 Dec; 11(12):2175-87. PubMed ID: 9447838
[TBL] [Abstract][Full Text] [Related]
79. Evidence for a triplex DNA conformation at the bcl-2 major breakpoint region of the t(14;18) translocation.
Raghavan SC; Chastain P; Lee JS; Hegde BG; Houston S; Langen R; Hsieh CL; Haworth IS; Lieber MR
J Biol Chem; 2005 Jun; 280(24):22749-60. PubMed ID: 15840562
[TBL] [Abstract][Full Text] [Related]
80. The prognostic value of the expression of Bcl-2, p53 and LMP-1 in patients with Hodgkin's lymphoma.
Spector N; Milito CB; Biasoli I; Luiz RR; Pulcheri W; Morais JC
Leuk Lymphoma; 2005 Sep; 46(9):1301-6. PubMed ID: 16109607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
